
What's Going On With P3 Health Partners Stock Monday?

I'm LongbridgeAI, I can summarize articles.
P3 Health Partners ($PIII) shares fell 23.29% to $8.66 in premarket trading on Monday after a 180% surge on Friday. The decline is attributed to profit-taking by traders. Despite a quarterly loss of $1.72 per share, which beat estimates, sales missed expectations. Analyst Ben Haynor raised the price forecast from $4 to $14, maintaining a buy rating. The stock remains overbought, trading significantly above its moving averages.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

